For those suffering from PTSD, traditional treatments oftentimes fall short when it comes to alleviating symptoms. Antidepressants are effective in only about 40 percent of patients, and benzodiazepines—while commonly prescribed as a treatment for PTSD may actually worsen symptoms. A study recently published in the Journal of Clinical Psychiatry revealed that PTSD patients who were prescribed benzodiazepines were almost twice as likely to attempt suicide. It goes without saying that PTSD patients need and deserve a more effective suite of treatment options.
More than 20 veterans commit suicide every day. Organizations such as 22 Kill and Active Heroes have brought a lot of awareness to the mental healthcare needs of those who have served our nation, but the truth is, no matter how aware we are of suicidality in veterans, they are still choosing to take their own lives at a rate higher than any other population of people.
Since the antidepressant effects of ketamine were discovered, its seems as though a Pandora’s Box of new uses for the medicine has been opened. Recent studies by the Columbia University Medical Center show that ketamine may prevent PTSD from developing in individuals who will experience a trauma – an especially hopeful discovery for our nation’s soldiers and first responders. Ketamine has also shown promise as an alcohol and cocaine addiction treatment. All of this on top of already being used to effectively alleviate chronic pain, treat depression and mood disorders, and – of course – as an anesthetic.